Virtual advisory boards: what pharma learned in 2020 and new trends for the Post-COVID Era
The COVID-19 pandemic accelerated the shift from face-to-face (F2F) to digital advisory boards for KOLs and HCPs. Surveys show strong adoption and preference for virtual formats, especially asynchronous discussions. MphaR’s platform achieves high satisfaction (NPS 96%), enabling cost-effective, efficient, and insight-rich interactions.